Navigation Links
Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
Date:9/7/2010

Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer -- SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer

 

SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Minghe Cheng as Chief Strategic Officer of the Company, effective as of September 6, 2010. Mr. Cheng's role will primarily include business model development, short and long-term strategic program planning and corporate structure and operation-process optimization.

"Mr. Cheng's extensive breadth of experience with Mindray's strategy and development makes him the ideal choice for this position," commented Mr. Xu Hang, Mindray's Chairman and Co-Chief Executive Officer. "We are confident that Mr. Cheng will continue to add value to Mindray's brand and play an instrumental role in helping the company benefit from new business and market opportunities."

"I look forward to my new role in developing both short and long-term strategic plans for each of our existing product lines as well as searching for new opportunities to aid the rapid and healthy expansion of Mindray's overall business," added Mr. Minghe Cheng. "There is great potential for Mindray, and given our innovative approach and strategic thinking backed by effective operations, we believe we are well-positioned to capitalize on these new opportunities."

As a co-founder of Mindray, Mr. Cheng has served 17 years in various roles across Mindray's sales, marketing and strategic development departments since the Company's establishment. Mr. Cheng received his bachelor's and master's degrees in biomedical engineering from Shanghai Jiaotong University.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

For investor and media inquiries, please contact: In the U.S.: Bryan Armstrong FD Tel: +1-312-553-6707 Email: bryan.armstrong@fd.com John Capodanno FD Tel: +1-212-850-5705 Email: john.capodanno@fd.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: ir@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. /C O R R E C T I O N - Mindray Medical International Limited /
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. West Pharmaceutical Services, Inc. Appoints New Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):